A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial (Q46708832)
Jump to navigation
Jump to search
scientific article published in September 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial |
scientific article published in September 2005 |
Statements
1 reference
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial (English)
1 reference
1 reference
1 reference
1 reference
1 reference
Steven R Steinhubl
1 reference
Gilles Montalescot
1 reference
Deepak L Bhatt
1 reference
Peter B Berger
1 reference
S Claiborne Johnston
1 reference
Eric A Cohen
1 reference
Steven M Haffner
1 reference
William E Boden
1 reference
Keith A Fox
1 reference
Werner Hacke
1 reference
Henry R Black
1 reference
Mark A Creager
1 reference
J Donald Easton
1 reference
Marcus D Flather
1 reference
Christian W Hamm
1 reference
Koon-Hou Mak
1 reference
Jean-Louis Mas
1 reference
Thomas A Pearson
1 reference
Michael A Weber
1 reference
Joan Booth
1 reference
CHARISMA Investigators
1 reference
1 September 2005
1 reference
150
1 reference
3
1 reference
401
1 reference